Spero Therapeutics to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying,...
Day: November 17, 2021
Peer Reviewed Study Demonstrates MIMEDX Dehydrated Human Amnion Chorion Membrane (dHACM) Outperforms Standard of Care in Select Mohs Defect Reconstructions
MIMEDX PURION® Processed Placental Allografts Proved Safer Than Autologous Tissue, Reducing Infection, Scarring and Reoperation Rates MARIETTA, Ga., Nov. 17,...
MedArrive Announces $25 Million in Series A Funding to Bridge the Virtual Care Gap
Led by Section 32, new capital will accelerate platform buildout, network expansion to bring affordable at-home care to vulnerable populations...
HTG and Icahn School of Medicine at Mount Sinai Announce Bladder Cancer Research Collaboration
HTG’s Innovative Transcriptome Panel Technology to be Leveraged in Retrospective StudiesTUCSON, Ariz., Nov. 17, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics,...
Frontier Medicines Announces the Appointment of Marguerite Hutchinson, J.D., as Chief Business Officer
SOUTH SAN FRANCISCO, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock...
OWP Pharmaceuticals Announces IND Authorization for the First-Ever Oral Liquid Formulation of Atomoxetine Hydrochloride for the Treatment of Attention Deficit Hyperactivity Disorder
NAPERVILLE, Ill., Nov. 17, 2021 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc. is a privately held, commercial-stage neuroscience specialty pharmaceutical company,...
ORYZON Enrolls First Patient in EVOLUTION, a Phase IIb Clinical Trial With Vafidemstat in Schizophrenia
Primary objectives: to assess the effect of vafidemstat to address negative and cognitive symptoms in schizophreniaPhase IIb adaptive trial planning...
CoImmune, Inc. Announces Research Collaboration with Yeda Research and Development Company Ltd.
The agreement will support research on applications of the Synthetic Immune Niche technology, developed at the Weizmann Institute of Science...
Fulcrum Therapeutics® Appoints Sonja L. Banks to its Board of Directors
CAMBRIDGE, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives...
Aquestive Therapeutics to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference
WARREN, N.J., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company focused on developing and...
Inspire Medical Systems, Inc. to Present at the Piper Sandler 33rd Annual Healthcare Conference
MINNEAPOLIS, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on...
Zosano Pharma Announces the Successful Formulation of a COVID-19 Vaccine Candidate on its Microneedle Patch System
FREMONT, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced the successful formulation...
Microinvasive Glaucoma Surgery with the OMNI® Surgical System is Associated with Diminished Diurnal IOP Fluctuations, a Significant, Independent Risk Factor for Glaucoma Progression
12-Month OMNI data from the prospective, multicenter GEMINI clinical trial show statistically significant postoperative reductions in mean IOP and suppression...
Kymera Therapeutics to Host Virtual R&D Day on December 16, 2021
WATERTOWN, Mass., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein...
Pasithea Therapeutics Launches In-Home Intravenous Ketamine Therapy in Major U.S. Cities, Expanding its International Footprint
-- Pasithea Clinics to offer ketamine infusion therapy for the treatment of mental health disorders -- -- First mobile clinics...
BiomX Presenting at Two Upcoming Conferences in November
Jefferies London Healthcare Conference on November 18 - 19, 2021 2021 Phage Futures Congress Europe on November 23 - 24,...
Science 37® Reveals a Pivotal Shift in the Clinical Trials Landscape
New data suggest that, for the first time, research sponsors and CROs plan to run more agile or hybrid clinical...
Way2Grow (W2G) Biopharma Corp. Receives Health Canada Approval Notice for Construction of a Controlled Substances Dealer’s Licence Level 8 Psychedelic Secure Environ and Psilocybin Production Campus
OSOYOOS, British Columbia, Nov. 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Way2Grow Biopharma Corp. (“W2G” or the “Company”), a...
Abeona Therapeutics Announces Presentation on Pivotal Transpher A Study of ABO-102 in MPS IIIA at the 14th ICIEM Conference
NEW YORK and CLEVELAND, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene...
Quipt Announces Strategic Acquisition of Biomedical Services Company in the Southeastern United States
Acquisition Provides Quipt Expansionary Opportunity Into Additional Long Term Care Facilities, Hospital Systems and Other Medical FacilitiesCINCINNATI, Nov. 17, 2021...
